Benzoyl peroxide

Last updated

Benzoyl peroxide
Benzoyl-peroxide.svg
Benzoyl-peroxide-from-xtal-3D-bs-17.png
Skeletal formula (top) Ball-and-stick model (bottom)
Clinical data
Trade names Benzac, Panoxyl, others
Other namesbenzoperoxide, dibenzoyl peroxide (DBPO), BPO
AHFS/Drugs.com Professional Drug Facts
MedlinePlus a601026
License data
Routes of
administration 		Topical
ATC code
Legal status
Legal status
Identifiers
  • benzoic peroxyanhydride [4]
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.002.116 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C14H10O4
Molar mass 242.230 g·mol−1
3D model (JSmol)
Density 1.334 g/cm3
Melting point 103 to 105 °C (217 to 221 °F) decomposes
Solubility in water poor mg/mL (20 °C)
  • c1ccc(cc1)C(=O)OOC(=O)c2ccccc2
  • InChI=1S/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10H
  • Key:OMPJBNCRMGITSC-UHFFFAOYSA-N
Data page
Benzoyl peroxide (data page)

Benzoyl peroxide is a chemical compound (specifically, an organic peroxide) with structural formula (C6H5−C(=O)O−)2, often abbreviated as (BzO)2. In terms of its structure, the molecule can be described as two benzoyl (C6H5−C(=O)−, Bz) groups connected by a peroxide (−O−O−). It is a white granular solid with a faint odour of benzaldehyde, poorly soluble in water but soluble in acetone, ethanol, and many other organic solvents. Benzoyl peroxide is an oxidizer, which is principally used in the production of polymers. [5]

Contents

Benzoyl peroxide is mainly used in production of plastics [5] [6] and for bleaching flour, hair, plastics and textiles. [7] [8]

As a bleach, it has been used as a medication and a water disinfectant. [6] [8]

As a medication, benzoyl peroxide is mostly used to treat acne, either alone or in combination with other treatments. [9] Some versions are sold mixed with antibiotics such as clindamycin. [10] [11] It is on the World Health Organization's List of Essential Medicines. [12] It is available as an over-the-counter and generic medication. [13] [10] It is also used in dentistry for teeth whitening. In 2021, it was the 284th most commonly prescribed medication in the United States, with more than 700,000 prescriptions. [14] [15]

History

Benzoyl peroxide was first prepared and described by Justus von Liebig in 1858. [16] Donald Holroyde Hey FRS [17] (12 September 1904 – 21 January 1987) was a Welsh organic chemist who inferred that the decomposition of benzoyl peroxide generated free phenyl radicals. [18] [19]

Structure and reactivity

Structure of dibenzoyl peroxide from X-ray crystallography. The O=C-O-O dihedral angle is 90deg. The O-O distance is 1.434 A. Dibenzoyl peroxide (CSD code =DBEZPO01).png
Structure of dibenzoyl peroxide from X-ray crystallography. The O=C-O-O dihedral angle is 90°. The O-O distance is 1.434 Å.

The original 1858 synthesis by Liebig reacted benzoyl chloride with barium peroxide, [16] a reaction that probably follows this equation:

2 C6H5C(O)Cl + BaO2 → (C6H5CO)2O2 + BaCl2

Benzoyl peroxide is usually prepared by treating hydrogen peroxide with benzoyl chloride under alkaline conditions.

2 C6H5COCl + H2O2 + 2 NaOH → (C6H5CO)2O2 + 2 NaCl + 2 H2O

The oxygen–oxygen bond in peroxides is weak. Thus, benzoyl peroxide readily undergoes homolysis (symmetrical fission), forming free radicals:

(C6H5CO)2O2 → 2 C
6H
5CO•
2

The symbol • indicates that the products are radicals; i.e., they contain at least one unpaired electron. Such species are highly reactive. The homolysis is usually induced by heating. The half-life of benzoyl peroxide is one hour at 92 °C. At 131 °C, the half-life is one minute. [21]

In 1901, it was observed that the compound made the tincture of guaiacum tincture turn blue, a sign of oxygen being released. [22] Around 1905, Loevenhart reported on the successful use of benzoyl peroxide to treat various skin conditions, including burns, chronic varicose leg tumors, and tinea sycosis. He also reported animal experiments that showed the relatively low toxicity of the compound. [23] [7] [24]

Treatment with benzoyl peroxide was proposed for wounds in 1929, and for sycosis vulgaris and acne varioliformis in 1934. [24] However, preparations were often of questionable quality. [7] It was officially approved for the treatment of acne in the US in 1960. [7]

Polymerization

Benzoyl peroxide is mainly used as a radical initiator to induce chain-growth polymerization reactions, [5] such as for polyester and poly(methyl methacrylate) (PMMA) resins and dental cements and restoratives. [25] It is the most important among the various organic peroxides used for this purpose, a relatively safe alternative to the much more hazardous methyl ethyl ketone peroxide. [26] [27] It is also used in rubber curing and as a finishing agent for some acetate yarns. [25]

Other uses

Tube of a water-based 5% benzoyl peroxide preparation for the treatment of acne Benzoyl peroxide gel.jpg
Tube of a water-based 5% benzoyl peroxide preparation for the treatment of acne

Benzoyl peroxide is effective for treating acne lesions. It does not induce antibiotic resistance. [28] [29] It may be combined with salicylic acid, sulfur, erythromycin or clindamycin (antibiotics), or adapalene (a synthetic retinoid). Two common combination drugs include benzoyl peroxide/clindamycin and adapalene/benzoyl peroxide, adapalene being a chemically stable retinoid that can be combined with benzoyl peroxide [30] unlike tezarotene and tretinoin. Combination products such as benzoyl peroxide/clindamycin and benzoyl peroxide/salicylic acid appear to be slightly more effective than benzoyl peroxide alone for the treatment of acne lesions. [29] The combination tretinoin/benzoyl peroxide was approved for medical use in the United States in 2021.

Benzoyl peroxide for acne treatment is typically applied to the affected areas in gel, cream, or liquid, in concentrations of 2.5% increasing through 5.0%, and up to 10%. [28] No strong evidence supports the idea that higher concentrations of benzoyl peroxide are more effective than lower concentrations. [28]

Mechanism of action

Classically, benzoyl peroxide is thought to have a three-fold activity in treating acne. It is sebostatic, comedolytic, and inhibits growth of Cutibacterium acnes , the main bacterium associated with acne. [28] [31] In general, acne vulgaris is a hormone-mediated inflammation of sebaceous glands and hair follicles. Hormone changes cause an increase in keratin and sebum production, leading to blocked drainage. C. acnes has many lytic enzymes that break down the proteins and lipids in the sebum, leading to an inflammatory response. The free-radical reaction of benzoyl peroxide can break down the keratin, therefore unblocking the drainage of sebum (comedolytic). It can cause nonspecific peroxidation of C. acnes, making it bactericidal, [7] and it was thought to decrease sebum production, but disagreement exists within the literature on this. [31] [32]

Some evidence suggests that benzoyl peroxide has an anti-inflammatory effect as well. In micromolar concentrations it prevents neutrophils from releasing reactive oxygen species, part of the inflammatory response in acne. [32]

Side effects

Skin irritation due to benzoyl peroxide BenzoperoxideRx.JPG
Skin irritation due to benzoyl peroxide

Application of benzoyl peroxide to the skin may result in redness, burning, and irritation. This side effect is dose-dependent. [9] [13]

Because of these possible side effects, it is recommended to start with a low concentration and build up as appropriate, as the skin gradually develops tolerance to the medication. Skin sensitivity typically resolves after a few weeks of continuous use. [32] [33] Irritation can also be reduced by avoiding harsh facial cleansers and wearing sunscreen prior to sun exposure. [33]

One in 500 people experience hypersensitivity to benzoyl peroxide and are liable to experience burning, itching, crusting, and possibly swelling. [34] [35] About one-third of people experience phototoxicity under exposure to ultraviolet (UVB) light. [36]

Dosage

In the US, the typical concentration for benzoyl peroxide is 2.5% to 10% for both prescription and over-the-counter drug preparations that are used in treatment for acne. [37]

Other medical uses

Benzoyl peroxide is used in dentistry as a tooth whitening product. [38]

Safety

Explosion hazard

Benzoyl peroxide is potentially explosive [39] like other organic peroxides, and can cause fires without external ignition. The hazard is acute for the pure material, so the compound is generally used as a solution or a paste. For example, cosmetics contain only a small percentage of benzoyl peroxide and pose no explosion risk.

Toxicity

Benzoyl peroxide breaks down in contact with skin, producing benzoic acid and oxygen, neither of which is very toxic. [40]

The carcinogenic potential of benzoyl peroxide has been investigated. A 1981 study published in the journal Science found that although benzoyl peroxide is not a carcinogen, it does promote cell growth when applied to an initiated tumor. The study concluded, "caution should be recommended in the use of this and other free radical-generating compounds". [41]

A 1999 IARC review of carcinogenicity studies found no convincing evidence linking benzoyl peroxide acne medication to skin cancers in humans. However, some animal studies found that the compound could act as a carcinogen and enhance the effect of known carcinogens. [25]

Benzoyl peroxide can break down into carcinogen benzene at temperatures above 50 °C. [42] [43]

Skin irritation

In a 1977, study using a human maximization test, 76% of subjects acquired a contact sensitization to benzoyl peroxide. Formulations of 5% and 10% were used. [44]

The US National Institute for Occupational Safety and Health has developed criteria for a recommended standard for occupational exposure to benzoyl peroxide. [45]

Cloth staining

A bleached fabric stain caused by contact with benzoyl peroxide Benzoyl peroxide stain.jpg
A bleached fabric stain caused by contact with benzoyl peroxide

Contact with fabrics or hair, such as from still-moist acne medication, can cause permanent color dampening almost immediately. Even secondary contact can cause bleaching, for example, contact with a towel that has been used to wash off benzoyl peroxide-containing hygiene products. [46]

See also

Related Research Articles

<span class="mw-page-title-main">Acne</span> Skin condition characterized by pimples

Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to lack of confidence, anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.

<span class="mw-page-title-main">Minocycline</span> Antibiotic medication

Minocycline, sold under the brand name Minocin among others, is a tetracycline antibiotic medication used to treat a number of bacterial infections such as some occurring in certain forms of pneumonia. It is generally less preferred than the tetracycline doxycycline. Minocycline is also used for the treatment of acne and rheumatoid arthritis. It is taken by mouth or applied to the skin.

<span class="mw-page-title-main">Sebaceous gland</span> Gland to lubricate the hair and skin

A sebaceous gland or oil gland is a microscopic exocrine gland in the skin that opens into a hair follicle to secrete an oily or waxy matter, called sebum, which lubricates the hair and skin of mammals. In humans, sebaceous glands occur in the greatest number on the face and scalp, but also on all parts of the skin except the palms of the hands and soles of the feet. In the eyelids, meibomian glands, also called tarsal glands, are a type of sebaceous gland that secrete a special type of sebum into tears. Surrounding the female nipples, areolar glands are specialized sebaceous glands for lubricating the nipples. Fordyce spots are benign, visible, sebaceous glands found usually on the lips, gums and inner cheeks, and genitals.

<i>Cutibacterium acnes</i> Species of bacterium

Cutibacterium acnes is the relatively slow-growing, typically aerotolerant anaerobic, gram-positive bacterium (rod) linked to the skin condition of acne; it can also cause chronic blepharitis and endophthalmitis, the latter particularly following intraocular surgery. Its genome has been sequenced and a study has shown several genes can generate enzymes for degrading skin and proteins that may be immunogenic.

<span class="mw-page-title-main">Clindamycin</span> Antibiotic

Clindamycin is a lincosamide antibiotic medication used for the treatment of a number of bacterial infections, including osteomyelitis (bone) or joint infections, pelvic inflammatory disease, strep throat, pneumonia, acute otitis media, and endocarditis. It can also be used to treat acne, and some cases of methicillin-resistant Staphylococcus aureus (MRSA). In combination with quinine, it can be used to treat malaria. It is available by mouth, by injection into a vein, and as a cream or a gel to be applied to the skin or in the vagina.

<span class="mw-page-title-main">Tretinoin</span> Medication

Tretinoin, also known as all-trans retinoic acid (ATRA), is a medication used for the treatment of acne and acute promyelocytic leukemia. For acne, it is applied to the skin as a cream, gel or ointment. For acute promyelocytic leukemia, it is effective only when the RARA-PML fusion mutation is present and is taken by mouth for up to three months. Topical tretinoin is also the most extensively investigated retinoid therapy for photoaging.

<span class="mw-page-title-main">Rosacea</span> Skin condition, usually on the face

Rosacea is a long-term skin condition that typically affects the face. It results in redness, pimples, swelling, and small and superficial dilated blood vessels. Often, the nose, cheeks, forehead, and chin are most involved. A red, enlarged nose may occur in severe disease, a condition known as rhinophyma.

ATC code D10Anti-acne preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D10 is part of the anatomical group D Dermatologicals.

<span class="mw-page-title-main">Adapalene</span> Third-generation topical retinoid

Adapalene, sold under the brand name Differin among others, is a third-generation topical retinoid primarily used in the treatment of mild-moderate acne, and is also used off-label to treat keratosis pilaris as well as other skin conditions. Studies have found adapalene is as effective as other retinoids, while causing less irritation. It also has several advantages over other retinoids. The adapalene molecule is more stable compared to tretinoin and tazarotene, which leads to less concern for photodegradation. It is also chemically more stable compared to the other two retinoids, allowing it to be used in combination with benzoyl peroxide. Due to its effects on keratinocyte proliferation and differentiation, adapalene is superior to tretinoin for the treatment of comedonal acne and is often used as a first-line agent. The Swiss company Galderma developed adapalene.

<span class="mw-page-title-main">Pseudofolliculitis barbae</span> Medical condition

Pseudofolliculitis barbae (PFB) is a type of irritant folliculitis that commonly affects people who have curly or coarse facial hair. It occurs when hair curls back into the skin after shaving, causing inflammation, redness, and bumps. This can lead to ingrown hairs, scarring, and skin discoloration. PFB can be treated with various methods, including changing shaving habits, using topical creams or ointments, and undergoing laser hair removal. Prevention measures include proper shaving techniques, using sharp razors, and avoiding too close a shave.

<span class="mw-page-title-main">Tazarotene</span> Topical retinoid medication

Tazarotene, sold under the brand name Tazorac, among others, is a third-generation prescription topical retinoid. It is primarily used for the treatment of plaque psoriasis and acne. Tazarotene is also used as a therapeutic for photoaged and photodamaged skin. It is a member of the acetylenic class of retinoids.

<span class="mw-page-title-main">Proactiv</span> Acne focused skincare products

Proactiv is an American brand of skin-care products developed by two American dermatologists, Katie Rodan and Kathy A. Fields, and launched in 1995 by Guthy-Renker, a California-based direct marketing company, that was endorsed by famous celebrities The range includes moisturizers, body washes and treatment products, but the brand is known for its three-step anti-acne Solutions 3-step routine consisting of a BPO cleanser, glycolic toner and treatment lotion. Proactiv+, a reformulation of the three-step kit, was introduced in 2013, and in 2017, ProactivMD launches powered by Adapalene.

<span class="mw-page-title-main">Clindamycin/benzoyl peroxide</span> Type of medication

Clindamycin/benzoyl peroxide, sold under the brand name Benzaclin among others, is a topical gel used for the treatment of acne. It is a fixed-dose combination of clindamycin, as the phosphate, an antibiotic; and benzoyl peroxide, an antiseptic.

<span class="mw-page-title-main">Pitted keratolysis</span> Medical condition

Pitted keratolysis is a bacterial skin infection of the foot. The infection is characterized by craterlike pits on the sole of the feet and toes, particularly weight-bearing areas.

<span class="mw-page-title-main">Neonatal acne</span> Medical condition

Neonatal acne, also known as acne neonatorum, is a type of acne that develops in newborns, typically within the first six weeks of life. It presents with open and closed comedones on the cheeks, chin and forehead.

<span class="mw-page-title-main">Pimple</span> Type of comedo

A pimple or zit is a kind of comedo that results from excess sebum and dead skin cells getting trapped in the pores of the skin. In its aggravated state, it may evolve into a pustule or papule. Pimples can be treated by acne medications, antibiotics, and anti-inflammatories prescribed by a physician, or various over the counter remedies purchased at a pharmacy.

<span class="mw-page-title-main">Adapalene/benzoyl peroxide</span> Pharmaceutical combination

Adapalene/benzoyl peroxide, sold under the brand name Epiduo among others, is a fixed-dose combination medication for the treatment of acne vulgaris. It is a combination of adapalene, a retinoid; and benzoyl peroxide.

Infantile acne is a form of acne that begins in very young children. Typical symptoms include inflammatory and noninflammatory lesions, papules and pustules most commonly present on the face. No cause of infantile acne has been established but it may be caused by increased sebaceous gland secretions due to elevated androgens, genetics and the fetal adrenal gland causing increased sebum production. Infantile acne can resolve by itself by age 1 or 2. However, treatment options include topical benzyl peroxide, topical retinoids and topical antibiotics in most cases.

Tretinoin/benzoyl peroxide, sold under the brand name Twyneo, is a fixed-dose combination medication used for the treatment of acne. It contains tretinoin, a vitamin A derivative, and benzoyl peroxide, an oxidizing agent.

Clindamycin/adapalene/benzoyl peroxide, sold under the brand name Cabtreo, is a fixed-dose combination medication used for the treatment of acne. It contains clindamycin, as the phosphate, a lincosamide antibacterial; adapalene, a synthetic retinoid; and benzoyl peroxide, an oxidizing agent. It is applied to the skin.

References

  1. ↑ "Therapeutic Goods (Poisons Standard—October 2024) Instrument 2024". Federal Register of Legislation. 30 September 2024. Retrieved 19 December 2024.
  2. ↑ "Epsolay- benzoyl peroxide cream". DailyMed. 25 April 2022. Archived from the original on 16 May 2022. Retrieved 15 May 2022.
  3. ↑ "Epsolay- benzoyl peroxide cream". DailyMed. 5 May 2022. Archived from the original on 20 June 2022. Retrieved 19 June 2022.
  4. ↑ IUPAC Chemical Nomenclature and Structure Representation Division (2013). "P-65.7.5". In Favre HA, Powell WH (eds.). Nomenclature of Organic Chemistry: IUPAC Recommendations and Preferred Names 2013. IUPAC–RSC. ISBN   978-0-85404-182-4.
  5. 1 2 3 Herbert K, Götz PH, Siegmeier R, Mayr W. "Peroxy Compounds, Organic". Ullmann's Encyclopedia of Industrial Chemistry . Weinheim: Wiley-VCH. doi:10.1002/14356007.a19_199. ISBN   978-3527306732.
  6. 1 2 Stellman JM (1998). Encyclopaedia of Occupational Health and Safety: Guides, indexes, directory. International Labour Organization. p. 104. ISBN   978-92-2-109817-1. Archived from the original on 18 September 2017.
  7. 1 2 3 4 5 Plewig G, Kligman AM (2012). ACNE and ROSACEA (3 ed.). Springer Science & Business Media. p. 613. ISBN   978-3-642-59715-2. Archived from the original on 18 September 2017.
  8. 1 2 Pommerville JC (2012). Alcamo's Fundamentals of Microbiology: Body Systems. Jones & Bartlett Publishers. p. 214. ISBN   978-1-4496-0595-7. Archived from the original on 18 September 2017.
  9. 1 2 World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 307–308. hdl:10665/44053. ISBN   978-92-4-154765-9.
  10. 1 2 British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. p. 820. ISBN   978-0-85711-156-2.
  11. ↑ Braun-Falco O, Plewig G, Wolff HH, Burgdorf W (2012). Dermatology (2 ed.). Springer Science & Business Media. p. 1039. ISBN   978-3-642-97931-6. Archived from the original on 18 September 2017.
  12. ↑ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl: 10665/371090 . WHO/MHP/HPS/EML/2023.02.
  13. 1 2 Hamilton R (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 173. ISBN   978-1-284-05756-0.
  14. ↑ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
  15. ↑ "Benzoyl Peroxide - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
  16. 1 2 Brodie BC (1858). "Ueber die Bildung der Hyperoxyde organischer Säureradicale" [On the Formation of the Peroxides of Organic Acid Radicals]. Justus Liebigs Ann. Chem. 108: 79–83. doi:10.1002/jlac.18581080117. Archived from the original on 29 November 2020. Retrieved 2 July 2019.
  17. ↑ Cadogan JI, Davies DI (1988). "Donald Holroyde Hey. 12 September 1904-21 January 1987". Biographical Memoirs of Fellows of the Royal Society . 34: 294–320. doi: 10.1098/rsbm.1988.0011 . JSTOR   770054.
  18. ↑ Hey DH (1934). "432. Amphoteric aromatic substitution. Part II. Reactions of benzoyl peroxide and phenylazotriphenylmethane". Journal of the Chemical Society (Resumed): 1966. doi:10.1039/JR9340001966.
  19. ↑ Davies J, Jenkins N, Menna B, Lynch PI, eds. (2008). The Welsh Academy Encyclopaedia of Wales. Cardiff: University of Wales Press. pp. 367–368. ISBN   978-0-7083-1953-6.
  20. ↑ McBride JM, Vary MW (1982). "Radical pair in crystalline dibenzoyl peroxide evidence for triplet ground states". Tetrahedron. 38 (6): 765–775. doi:10.1016/0040-4020(82)80157-9.
  21. ↑ Li III H (1998). "Chapter 2" (PDF). Synthesis, Characterization and Properties of Vinyl Ester Matrix Resins (Ph.D.). University of Vermont. hdl:10919/30521. Archived from the original on 20 September 2006. Retrieved 17 February 2007.
  22. ↑ Kastle JH, Loevenhart AS (1901). "On the Nature of Certain Oxidizing Ferments". American Chemical Journal. 2: 539–566.
  23. ↑ Loevenhart AS (1905). "Benzoylsuperoxyds, ein neues therapeutisches Agens". Therap Monatscheftel (in German). 12: 426–428.
  24. 1 2 Merker PC (March 2002). "Benzoyl peroxide: a history of early research and researchers". International Journal of Dermatology. 41 (3): 185–8. doi:10.1046/j.1365-4362.2002.01371.x. PMID   12010349. S2CID   24091844.
  25. 1 2 3 International Agency for Research on Cancer (1999): "Benzoyl peroxide". in Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide Archived 15 July 2020 at the Wayback Machine . Monographs on the Evaluation of Carcinogenic Risks to Humans, number 71, pages 345–358. ISBN   92-832-1271-1
  26. ↑ "Initiation By Diacyl Peroxides". Polymer Properties Database. Archived from the original on 19 October 2018. Retrieved 19 October 2018.
  27. ↑ "Error - Evonik Industries AG" (PDF). Archived from the original on 29 August 2021. Retrieved 12 April 2011.
  28. 1 2 3 4 Simonart T (December 2012). "Newer approaches to the treatment of acne vulgaris". American Journal of Clinical Dermatology. 13 (6): 357–64. doi:10.2165/11632500-000000000-00000. PMID   22920095. S2CID   12200694.
  29. 1 2 Seidler EM, Kimball AB (July 2010). "Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne". Journal of the American Academy of Dermatology. 63 (1): 52–62. doi:10.1016/j.jaad.2009.07.052. PMID   20488582.
  30. ↑ Tolaymat L, Dearborn H, Zito PM (2022). "Adapalene". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID   29494115 . Retrieved 24 July 2022.
  31. 1 2 Cotterill JA (1 January 1980). "Benzoyl peroxide". Acta Dermato-Venereologica. Supplementum. 89: 57–63. doi: 10.2340/00015555895763 . PMID   6162349.
  32. 1 2 3 Worret WI, Fluhr JW (April 2006). "[Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid]" [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology (in German). 4 (4): 293–300. doi:10.1111/j.1610-0387.2006.05931.x. PMID   16638058. S2CID   6924764.
  33. 1 2 Alldredge BK, Koda-Kimble MA, Young LY, eds. (2013). Applied Therapeutics: The Clinical Use of Drugs (10th ed.). Baltimore: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 949. ISBN   978-1-60913-713-7.
  34. ↑ Cunliffe WJ, Burke B (1982). "Benzoyl peroxide: lack of sensitization". Acta Dermato-Venereologica. 62 (5): 458–9. doi: 10.2340/0001555562458459 . PMID   6183909.
  35. ↑ "Benzoyl peroxide". Mayo Clinic. 1 January 2016. Archived from the original on 18 July 2016.
  36. ↑ Jeanmougin M, Pedreiro J, Bouchet J, Civatte J (1 January 1983). "[Phototoxic activity of 5% benzoyl peroxide in man. Use of a new methodology]". Dermatologica. 167 (1): 19–23. doi:10.1159/000249739. PMID   6628794.
  37. ↑ "Benzoyl Peroxide: Side Effects, Uses, Dosage, Interactions, Warnings". RxList. Retrieved 11 August 2024.
  38. ↑ "Some Facts On Teeth Whitening". worldofdentistry.co.in. Retrieved 6 November 2024.
  39. ↑ Cartwright H (17 March 2005). "Chemical Safety Data: Benzoyl peroxide". Oxford University. Archived from the original on 12 October 2010. Retrieved 13 August 2011.
  40. ↑ Benzoyl peroxide (PDF), SIDS Initial Assessment Report, Geneva: United Nations Environment Programme, April 2004
  41. ↑ Slaga TJ, Klein-Szanto AJ, Triplett LL, Yotti LP, Trosko KE (August 1981). "Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound". Science. 213 (4511): 1023–5. Bibcode:1981Sci...213.1023S. doi:10.1126/science.6791284. PMID   6791284.
  42. ↑ Kucera K, Zenzola N, Hudspeth A, Dubnicka M, Hinz W, Bunick CG, et al. (March 2024). "Benzoyl Peroxide Drug Products Form Benzene". Environmental Health Perspectives. 132 (3): 37702. Bibcode:2024EnvHP.132c7702K. doi:10.1289/EHP13984. PMC   10939128 . PMID   38483533.
  43. ↑ "USP Statement on Third Party Laboratory Benzene Findings | USP". www.usp.org. Retrieved 16 March 2024.
  44. ↑ Leyden JJ, Kligman AM (October 1977). "Contact sensitization to benzoyl peroxide". Contact Dermatitis. 3 (5): 273–5. doi:10.1111/j.1600-0536.1977.tb03674.x. PMID   145346. S2CID   33553359.
  45. ↑ "Criteria for a Recommended Standard: Occupational Exposure to Benzoyl Peroxide (77-166)". CDC - NIOSH Publications and Products. 6 June 2014. doi: 10.26616/NIOSHPUB76128 . Archived from the original on 9 August 2016. Retrieved 15 July 2016.
  46. ↑ Bojar RA, Cunliffe WJ, Holland KT (February 1995). "The short-term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora". The British Journal of Dermatology. 132 (2): 204–8. doi:10.1111/j.1365-2133.1995.tb05014.x. PMID   7888356. S2CID   22468429.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.